Description du projet
Surveiller les sons vitaux des personnes âgées
La charge des maladies chroniques en Europe est en augmentation et est principalement associée au vieillissement de la population. Les maladies chroniques imposent une charge financière considérable aux systèmes de santé. Une surveillance efficace des signes vitaux des personnes âgées est cruciale. Dans ce contexte, des chercheurs mettent au point des dispositifs innovants et peu invasifs permettant de surveiller les signes vitaux des personnes âgées dans les établissements de soins. Le projet RayVS1, financé par l’UE, mettra au point un capteur radar unique capable de détecter la position, les mouvements (détection des chutes), le rythme cardiaque et respiratoire des personnes placées dans des établissements de soins, sans aucune interaction physique avec l’utilisateur. Le capteur fournit des alertes en temps réel et personnalisées aux soignants et aux professionnels de la santé, tout en préservant les données personnelles des utilisateurs.
Objectif
Currently, Europe has the greatest percentage of population aged 65 or over (20%). As life expectancy is increasing there is
an increasing prevalence of chronic diseases which represents a major challenge for health systems. In fact, total ageing
costs in the EU are projected to reach 28.3% of GDP in 2060. Therefore, there is a huge need of developing innovative and
minimally invasive devices for monitoring elderly vital signs parameters and movements in care homes. The golden standard
methods are represented by smart sensors and camera systems. However, they lack in real-time alerting services, they
need constant physical interaction and have limited measurements capabilities. Raytelligence introduces the RayVS1, a
single radar sensor that can detect position, movement (fall detection), heart and respiration rate of persons in care homes
without the need of physically interact with the user. The sensor provides real-time and customized alerts to caregivers,
medical professionals and family members whenever the signals overcome predefined thresholds, through a dedicated
cloud application. This will ensure wide coverage (multiple people monitored with one sensor) and injury prevention thus
saving related healthcare costs. Moreover, it guarantees privacy to the users since personal data are securely stored into the
cloud and it ensures high precision and accurate motion measurements (20μm). RayVS1 has already obtained the CE mark
for in-home use. During the feasibility assessment, a go-to-market strategy and a supply chain will be established, as well as
further development plan will be drafted. During the second phase of innovation project, Raytelligence will optimize the
signal processing activity to monitor multiple individuals with one RayVS1 and extract another vital parameter, such as the
sleep quality. The production capacity will be increase up to 15k pieces per year. Validation trials will then be initiated for obtaining CE mark as a medical device.
Champ scientifique
- natural sciencescomputer and information sciencesinternetinternet of things
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensorsoptical sensors
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsignal processing
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensorssmart sensors
- engineering and technologyelectrical engineering, electronic engineering, information engineeringinformation engineeringtelecommunicationsradio technologyradar
Programme(s)
Régime de financement
SME-1 - SME instrument phase 1Coordinateur
302 42 HALMSTAD
Suède
L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention.